华佗品牌怎么样 申请店铺

更新时间:2024-10-26
华佗是哪个国家的品牌?「华佗」是 华佗国药股份有限公司 旗下著名品牌。该品牌发源于安徽,由创始人李宏良在2009期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
华佗怎么样

安徽华佗国药股份有限公司位于三朝古都,华佗故里,中国历史文化名城,全国四大药都之首—安徽省亳州市。安徽华佗国药股份有限公司已有50多年建厂历史,设计规模及生产能力居安徽前列,在全国也位列前茅;2001年又斥资上亿元,由省医药设计院,参照中外合资先进企业的优点和特色,经科学规划、精心设计、高标准建设、全面实施国家医药GMP工程,并于2002年12月8日一次性通过国家GMP认证,是国内第一批通过GMP认证的企业之一。

致力于发展传统的中医药文化,倡导安全用药,安心用药,秉承“用良心制好药”的理念,华佗国药厂自始就以质量控制为第一要务,厂内配有全进口日本岛津公司高效液相仪、气相色谱仪、薄层扫描仪、紫光分析仪等检测设备,堪称高起点,高标准的现代化中成药制造企业和中药材加工基地。厂内现有国内领先的全自动生产灌装线、自动颗粒包装机、自动胶囊填充机、自动铝塑包装机、全自动高效包衣机等现代化设备均完全符合国家GMP标准。并配有空压冷冻系统、净化系统、电视监控系统、数字化管理等一系列先进管理系统;为了进一步的提高中药现代化的进程,我们成立了安徽华佗现代中药研发中心,致力于中国中药现代化的研究与开发。

安徽华佗国药股份有限公司,目前具有年加工中药材5600吨的生产能力,产品有片剂、丸剂、胶囊剂、颗粒剂、单味药颗粒、中药饮片六大剂类型,60多个品种,年产值可达5.6亿元,产品大部分出口,畅销亚、欧、美三十多个国家和地区。在不久的将来,安徽华佗国药股份有限公司将成为中国最大的中成药生产企业和中药材加工基地。

在华佗国药厂的发展历史上,曾受到诸多中央和省市领导人的关心,国务院总理温家宝、副总理回良玉及安徽省历届主要党政领导人曾亲自前往华佗国药厂视察。

安徽华佗国药股份有限公司始终坚持“质量第一,诚信为本,用良心制好药”的经营理念,确保人民安全用药,保障人民身体健康,促进医药经济发展。竭诚欢迎海内外客商来厂洽谈业务,进行经贸合作。

Anhui Huatuo State Pharmaceutical Co., Ltd. is located in Bozhou City, Anhui Province, the capital of three dynasties, the hometown of Huatuo, the famous historical and cultural city of China and the first of the four major pharmaceutical capitals in China. Anhui Huatuo State Pharmaceutical Co., Ltd. has a history of more than 50 years. Its design scale and production capacity rank the top in Anhui Province, and it ranks the top in the country. In 2001, it also spent more than 100 million yuan. With reference to the advantages and characteristics of advanced Sino foreign joint ventures, the Provincial Pharmaceutical Design Institute carried out the national pharmaceutical GMP project through scientific planning, careful design, high standard construction and comprehensive implementation One time through the national GMP certification, is the first batch of domestic enterprises through GMP certification. Committed to the development of traditional Chinese medicine culture, advocating safe drug use, reassuring drug use, and adhering to the concept of "making good medicine with conscience", huatuoguo pharmaceutical factory has been focusing on quality control since the beginning. The factory is equipped with imported high-performance liquid chromatography, gas chromatograph, thin-layer scanner, violet light analyzer and other testing equipment of Shimadzu company of Japan, which can be regarded as a high starting point and a high standard of modernization Pharmaceutical manufacturing enterprises and traditional Chinese medicine processing bases. In the factory, the domestic leading full-automatic production filling line, automatic particle packaging machine, automatic capsule filling machine, automatic aluminum plastic packaging machine, automatic high-efficiency coating machine and other modern equipment are all in full compliance with the national GMP standards. In order to further improve the modernization process of traditional Chinese medicine, we have established Anhui Huatuo modern Chinese medicine research and development center, which is dedicated to the research and development of the modernization of traditional Chinese medicine. Anhui Huatuo State Pharmaceutical Co., Ltd. has an annual production capacity of processing 5600 tons of Chinese herbal medicines. Its products include six types of tablets, pills, capsules, granules, single drug granules and Chinese herbal pieces, with more than 60 varieties. Its annual output value can reach 560 million yuan. Most of its products are exported and sold well in more than 30 countries and regions in Asia, Europe and the United States. In the near future, Anhui Huatuo Guoyao Co., Ltd. will become the largest Chinese patent medicine manufacturer and Chinese herbal medicine processing base in China. In the development history of Huatuo state pharmaceutical factory, it has been concerned by many central and provincial leaders. Premier Wen Jiabao of the State Council, Vice Premier Hui Liangyu and major party and government leaders of Anhui Province have personally visited Huatuo state pharmaceutical factory. Anhui Huatuo State Pharmaceutical Co., Ltd. always adheres to the business philosophy of "quality first, integrity-based, making good medicine with conscience", so as to ensure people's safe drug use, ensure people's health and promote the development of medical economy. We sincerely welcome customers from home and abroad to come to our factory to discuss business and carry out economic and trade cooperation.

本文链接: https://brand.waitui.com/e16df2ef3.html 联系电话:0551-4669444

千城特选小程序码

7×24h 快讯

韩国央行行长称将关注汇率波动,而非设定具体的汇率目标

韩国央行行长李昌镛表示,韩国央行将关注汇率波动,而不是设定具体的汇率目标。如果汇率突破区间,韩国央行会考虑是否需要进行政策调整。(财联社)

24分钟前

特斯拉晋升迈克尔·斯奈德为能源与充电副总裁

10月26日,职业社交网站LinkedIn显示,特斯拉Megapack高级总监迈克尔·斯奈德(Michael Snyder)已获晋升为能源与充电副总裁。斯奈德于2014年6月加入特斯拉,于2022年8月担任Megapack高级主管,领导公司的Megapack项目。(界面)

24分钟前

机构:三季度全球AMOLED手机面板出货量同比、环比双增长

36氪获悉,10月26日,CINNO Research最新报告指出,随着苹果iPhone16系列等高端旗舰机型的发布,第三季度OLED面板的整体需求持续回升。根据CINNO Research统计数据显示,2024年第三季度全球AMOLED智能手机面板出货量约2.2亿片,同比增长25.3%,环比增长0.9%,同比、环比双增长。从柔性面板出货来看,2024年第三季度全球AMOLED智能手机面板中柔性AMOLED智能手机面板占比76.4%,同比下滑2.3个百分点,环比上升4.2个百分点。

24分钟前

上海机场明日将执行2024年冬春航班计划

36氪获悉,据上海机场集团消息,2024年10月27日至2025年3月29日,上海机场将执行2024年冬春航季航班计划。新航季中,上海机场日均计划执行航班2403架次(其中,浦东机场1627架次、虹桥机场776架次)。日均计划执行国内客运航班1646架次(其中,浦东机场915架次、虹桥机场731架次),同比持平;日均计划执行国际、港澳台客运航班561架次(其中,浦东机场516架次,虹桥机场45架次),同比增长5.2%。

24分钟前

加“新能源”减“红利”,公募基金进攻路线图显现

10月25日,公募基金2024年三季报披露完毕。公募基金最新前十大重仓股出炉,分别是宁德时代、贵州茅台、腾讯控股、立讯精密、美的集团、五粮液、紫金矿业、中际旭创、阳光电源、比亚迪。与2024年二季度末相比,阳光电源、比亚迪新进前十大重仓股,中国海洋石油、迈瑞医疗则退出前十大重仓股行列。随着市场在三季度末快速上涨,基金经理操作更为积极,调仓动作明显。整体来看,公募基金加仓了多只新能源龙头股,同时减持了前期涨幅较高的红利个股。(中证网)

24分钟前

本页详细列出关于华佗的品牌信息,含品牌所属公司介绍,华佗所处行业的品牌地位及优势。
咨询